GB1120249A - A method of two- or multistage continuous biotransformation or biosynthesis - Google Patents

A method of two- or multistage continuous biotransformation or biosynthesis

Info

Publication number
GB1120249A
GB1120249A GB34966/65A GB3496665A GB1120249A GB 1120249 A GB1120249 A GB 1120249A GB 34966/65 A GB34966/65 A GB 34966/65A GB 3496665 A GB3496665 A GB 3496665A GB 1120249 A GB1120249 A GB 1120249A
Authority
GB
United Kingdom
Prior art keywords
stage
micro
rate
growth
azauracil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB34966/65A
Inventor
Zdenek Fencl
Jan Ricica
Vladimir Munk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Czech Academy of Sciences CAS
Original Assignee
Czech Academy of Sciences CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Czech Academy of Sciences CAS filed Critical Czech Academy of Sciences CAS
Publication of GB1120249A publication Critical patent/GB1120249A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/02Monosaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

In a multi-stage process for continuous cultivation of micro-organisms on assimilable carbon, nitrogen and inorganic salts within a liquid substrate with the production of biochemical products, e.g. glucose oxidase and amino acids, or ribonucleic acid proportionately with the growth of micro-organisms, at any stage between the first and penultimate stages partly fermented substrate containing the micro-organism culture in a phase of retarded growth is transferred to a following fermentation stage in which the culture exists in a phase of exponential growth, and this following stage is then fed with fresh substrate. An additive which will act in the continuous process to yield a product but is toxic to the microorganism, may be introduced at the penultimate fermentation stage. According to Example 2, Aspergillus niger was grown in sugar-beet molasses (pH 6.0) in two stages at dilution rates of 0.04-0.05 (retarded growth) and 0.12-0.14 (exponential growth) respectively, giving optimum production of glucose oxidase. In Example 3, Escherichia coli was cultivated in two stages upon specified media, each containing 6-azauracil, to obtain ribonucleic acid. In the first stage the rate of synthesis of the ribonucleic acid was considerably reduced due to the inhibitory effect of the 6-azauracil, whereby the rate of 6-azauracil riboside synthesis corresponded to the rate of the ribonucleic acid synthesis.ALSO:In a multi-stage process for continuous cultivation of micro-organisms on assimilable carbon, nitrogen and inorganic salts within a liquid substrate with the production of biochemical products (sorbose, glucose oxidase, ribonucleic acid, antibiotics, amino acids and other organic acids) proportionately with the growth of micro-organisms, at any stage between the first and penultimate stages partly fermented substrate containing the micro-organism culture in a phase of retarded growth is transferred to a following fermentation stage in which the culture exists in a phase of exponential growth, and this following stage is then fed with fresh substrate. An additive which will act in the continuous process to yield a product but is toxic to the micro-organism, may be introduced at the penultimate fermentation stage. According to the Examples: (1) a culture of Acetobacter suboxidans was grown in a state of retarded growth upon a sorbitol substrate, containing additionally corn steep liquor, yeast extract, disodium hydrogen phosphate and sodium carbonate, at a dilution rate of 0.1 - 0.11. The fermented medium together with the micro-organism culture was passed into a second fermentation stage for exponential growth of the micro-organism, to which stage fresh substrate was being fed so that the total dilution rate in this stage was 0.45. There followed a third stage with the same dilution rate. The yield of sorbose amounted to 98% of the sorbitol processed. (2) Aspergillus niger was grown on sugar-beet molasses (pH 6.0) in two stages at dilution rates of 0.04 - 0.05 (retarded growth) and 0.12 - 0.14 (exponential growth) respectively, giving optimum production of glucose oxidase. (3) Escherichia coli was cultivated in two stages upon specified media containing 6-azauracil in the second stage, to obtain ribonucleic acid and azauracil riboside. The rate of synthesis of the ribonucleic acid was considerably reduced due to the inhibitory effect of the 6-azauracil, whereby the rate of 6-azauracil riboside synthesis corresponded to the rate of ribonudeic acid synthesis.ALSO:In a multi-stage process for continuous cultivation of micro-organisms on assimilable carbon, nitrogen and inorganic salts within a liquid substrate with the production of biochemical products (sorbose, glucose oxidase, ribonucleic acid, antibiotics, amino acids and other organic acids) proportionately with the growth of micro-organisms, at any stage between the first and penultimate stages partly fermented substrate containing the micro-organism culture in a phase of retarded growth is transferred to a following fermentation stage in which the culture exists in a phase of exponential growth, and this following stage is then fed with fresh substrate. An additive which will act in the continuous process to yield a product but is toxic to the micro-organism, may be introduced at the penultimate fermentation stage. According to the examples: (1) a culture of Acetobacter suboxidans was grown in a state of retarded growth upon a sorbitol substrate, containing additionally corn steep liquor, yeast extract, disodium hydrogen phosphate and sodium carbonate, at a dilution rate of 0.1-0.11. The fermented medium together with the micro-organism culture was passed into a second fermentation stage for exponential growth of the micro-organism, to which stage fresh substrate was being fed so that the total dilution rate in this stage was 0.45. There followed a third stage with the same dilution rate. The yield of sorbose amounted to 98% of the sorbitol processed. (2) Aspergillus niger was grown on sugar-beet molasses (pH 6.0) in two stages at dilution rates of 0.04-0.05 (retarded growth) and 0.12-0.14 (exponential growth) respectively, giving optimum production of glucose oxidase. (3) Escherichia coli was cultivated in two stages upon specified media containing 6-azauracil in the second stage, to obtain ribonucleic acid and azauracil riboside. The rate of synthesis of the ribonucleic acid was considerably reduced due to the inhibitory effect of the 6-azauracil, whereby the rate of 6-azauracil riboside synthesis corresponded to the rate of ribonucleic acid synthesis.
GB34966/65A 1964-09-22 1965-08-16 A method of two- or multistage continuous biotransformation or biosynthesis Expired GB1120249A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS526864 1964-09-22

Publications (1)

Publication Number Publication Date
GB1120249A true GB1120249A (en) 1968-07-17

Family

ID=5397237

Family Applications (1)

Application Number Title Priority Date Filing Date
GB34966/65A Expired GB1120249A (en) 1964-09-22 1965-08-16 A method of two- or multistage continuous biotransformation or biosynthesis

Country Status (2)

Country Link
DE (1) DE1442227A1 (en)
GB (1) GB1120249A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4307334A1 (en) * 1993-03-09 1994-09-15 Chema Balcke Duerr Verfahrenst Process and system for the production of inoculation material for improved crude oil production
EP0972843A1 (en) * 1998-07-17 2000-01-19 F. Hoffmann-La Roche Ag Continuous fermentation process
US6238897B1 (en) 1998-07-17 2001-05-29 Roche Vitamins Inc. Continuous process for producing 2-keto-L-gulonic acid

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4307334A1 (en) * 1993-03-09 1994-09-15 Chema Balcke Duerr Verfahrenst Process and system for the production of inoculation material for improved crude oil production
EP0972843A1 (en) * 1998-07-17 2000-01-19 F. Hoffmann-La Roche Ag Continuous fermentation process
US6238897B1 (en) 1998-07-17 2001-05-29 Roche Vitamins Inc. Continuous process for producing 2-keto-L-gulonic acid

Also Published As

Publication number Publication date
DE1442227A1 (en) 1969-01-23

Similar Documents

Publication Publication Date Title
NZ504345A (en) Low pH lactic acid fermentation
US3622463A (en) Production of extracellular glucose isomerase by streptomyces
GB1120249A (en) A method of two- or multistage continuous biotransformation or biosynthesis
EP0047641B2 (en) Ethanol production by high performance bacterial fermentation
FR2635334A1 (en) PROCESS FOR THE PRODUCTION OF LACTIC ACID BY FERMENTATION
US2643213A (en) Method for the production of vitamin b12 by streptomyces olivaceus
JP2695180B2 (en) Method for producing ascorbic acid-2-phosphate
US5770411A (en) Microbial process for the preparation of dihydroxyacetone with recycling of biomass
US5212079A (en) Process for the preparation of ascorbic acid-2-phosphate
US5869300A (en) Method for producing L-glutamic acid by continuous fermentation
PT668359E (en) CONTINUOUS FERTILIZATION PROCESS, USEFUL FOR THE OPTIMAL, SIMULTANEOUS, PROPIONIC ACID AND VITAMIN B12 PRODUCTION
US2557078A (en) Enzyme production
US3368947A (en) Process for producing nicotinamide dinucleotide
US3296090A (en) Fermentation process for producing 1-tryptophane
CZ279246B6 (en) Microbiological process for preparing sodium gluconate
US3255093A (en) Conversion of glucose to 2-ketogluconic acid
US2602768A (en) Process for the manufacture of sodium gluconate
US3411991A (en) Vitamin b12 fermentation
US2139111A (en) Process for the production of butyl alcohol by fermentation
US3028310A (en) Method of producing l-valine by fermentation
US4647534A (en) Ethanol production by high performance bacterial fermentation
US1928379A (en) Production of butyl alcohol and acetone by fermentation
US3328261A (en) Method for the fermentative production of 5-amino-4-imidazole carboxamide ribotide
Kawabata et al. Enzymatic synthesis of pantothenic acid by Escherichia Coli cells
US3298924A (en) Process for making penicillin amidase